Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 6;2024(1):700-708.
doi: 10.1182/hematology.2024000598.

Molecular landscape and classification of vascular anomalies

Affiliations
Review

Molecular landscape and classification of vascular anomalies

Emmanuel Seront et al. Hematology Am Soc Hematol Educ Program. .

Abstract

Vascular malformations, which result from anomalies in angiogenesis, include capillary, lymphatic, venous, arteriovenous, and mixed malformations and affect specific vessel types. Historically, treatments such as sclerotherapy and surgery have shown limited efficacy in complicated cases. Most vascular malformations occur sporadically, but some can be inherited. They result from mutations similar to oncogenic alterations, activating pathways such as PI3K-AKT-mTOR or Ras-MAPK-ERK. Recognizing these parallels, we highlight the potential of targeted molecular inhibitors, repurposing anticancer drugs for the treatment of vascular malformations. This case-based review explores recent developments in precision medicine for slow-flow and fast-flow vascular malformation.

PubMed Disclaimer

Conflict of interest statement

Emmanuel Seront: no competing financial interests to declare.

Angela Queisser: no competing financial interests to declare.

Laurence M. Boon: no competing financial interests to declare.

Miikka Vikkula: no competing financial interests to declare.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Brief overview of vascular malformation classification. CLOVES, congenital lipomatous overgrowth with vascular anomalies epidermal nevi and scoliosis; CLVM, capillary-lymphatic-venous malformations; CVM, capillary-venous malformation; KTS, Klippel- Trenaunay syndrome; LVM, lymphatic-venous malformations.
Figure 2.
Figure 2.
Signaling pathways involved in vascular malformations. CLOVES ,  congenital lipomatous overgrowth with vascular anomalies epidermal nevi and scoliosis; KTS, Klippel-Trenaunay syndrome; VEGFR,  vascular endothelial growth factor receptor.
Figure 3.
Figure 3.
Clinical case. (A) Extensive bluish lesions on left lower limb; (B) magnetic resonance imaging showing extensive venous malformation in most of the muscles of the thigh (blue arrows); (C) magnetic resonance imaging showing involvement of the perineal area (blue arrows); (D) evolution of symptoms (bleeding and visual analogue score of the pain on sirolimus with rapid arrest of bleeding after sirolimus initiation and recurrence of symptoms after arrest of sirolimus. The reintroduction of sirolimus at a lower dose subsequently controlled the symptoms.

References

    1. Mulliken JB, Glowacki J.. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69(3):412-422. - PubMed
    1. Queisser A, Seront E, Boon LM, Vikkula M.. Genetic basis and therapies for vascular anomalies. Circ Res. 2021;129(1):155-173. - PubMed
    1. Boscolo E, Limaye N, Huang L, et al.. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J Clin Invest. 2015;125(9):3491-3504. - PMC - PubMed
    1. Limaye N, Wouters V, Uebelhoer M, et al.. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet. 2009;41(1):118-124. - PMC - PubMed
    1. Seront E, Boon LM, Vikkula M.. TEK-related venous malformations. In: Adam MP, Mirzaa GM, Pagon RA, et al, eds. GeneReviews. University of Washington; 1993. - PubMed

LinkOut - more resources